By creating competition that can significantly reduce the prices of biologic medications, biosimilars create financial headroom for plan sponsors to offer coverage for innovative drug treatments.

These alternatives to biologics offer the opportunity for up to $375 billion in savings over the next 10 years

By supporting and encouraging evidence-based access to gene therapy, payers and other segments of U.S. society will be positioned to benefit from future advancements and biopharmaceutical breakthrough...

Working with the complex drug supply chain in the United States, PBMs like Express Scripts help drive competition to lower costs and combat the high price of prescription medications. In doing so, we ...

Accelerating the progress of biosimilars is key to lowering drug costs and improving patient access to potentially life-saving therapies.

Eric Palmer's career journey started with a summer internship at Cigna Healthcare. Today, he leads Evernorth Health Services, supporting employers and health plans in improving the health of their mem...

Value-based health care programs employ an array of innovative strategies to help keep costs in check.

To create a strong pipeline of early career technology talent, and create equitable opportunities for underrepresented students, Evernorth has partnered with Access Point – a program designed to provi...